CDx development Dec 23, 2020 Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China Sep 25, 2020 Genetron, CStone Launch Clinical Trial to Develop CDx for Cancer Drug Avapritinib Jun 23, 2020 Thermo Fisher Scientific, Daiichi Sankyo Partner to Develop Non-Small Cell Lung Cancer CDx Mar 30, 2020 Myriad Genetics Seeks Japan Approval for Advanced Pancreatic, Prostate Cancer Companion Diagnostic Mar 25, 2020 AmoyDx, Janssen Research and Development Partner on NGS-Based Companion Diagnostic Mar 24, 2020 SkylineDx, BioInvent Collaborate to Characterize Predictive Immunological Signatures for Cancers Mar 12, 2020 Thermo Fisher, Janssen Biotech to Develop CDx for Lung Cancer, Other Indications Dec 4, 2019 FDA Approves Foundation Medicine CDx for Novartis Breast Cancer Drug Piqray Nov 6, 2019 Merck, Promega Collaborate to Develop MSI CDx for Keytruda Sep 9, 2019 Thermo Fisher Scientific, Eli Lilly to Develop CDx for RET Inhibitor Jul 1, 2019 FDA Approves Foundation Medicine CDx Test for Lynparza May 30, 2019 Caris Life Sciences Inks CDx Collaboration With Debiopharm Apr 4, 2019 Myriad Genetics, AstraZeneca, Merck Expand BRCA CDx Collaboration Dec 7, 2018 Novartis Drug Shows Promise in PIK3CA Mutated Breast Cancer, Potential Utility of ctDNA Testing Premium Oct 16, 2018 FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug Jun 20, 2018 Merck KGaA Advancing Tepotinib in MET-Altered Cancer Subpopulations Premium Jun 14, 2018 Janssen Plans Year-End Erdafitinib Filing Based on Phase II Data in FGFR-Mutated Bladder Cancer Premium Jun 22, 2017 Thermo Fisher Next-Gen Sequencing Panel Wins FDA Approval as Companion Test Feb 28, 2017 Q&A: Labceutics' Jordan Clark on Industry, FDA Gap on Rx/Dx Codevelopment Principles Premium Sep 12, 2016 Opdivo Setback May Yield Lessons for Pharma Advancing Immunotherapies With PD-L1 Testing Premium Load More Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
